Definium Therapeutics, Inc. (DFTX) Q4 FY25 Earnings Call

Multiple 2026 pivotal readouts are approaching, backed by cash management says funds operations into 2028.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-01
Length67 minutes
EPS$-0.45
EPS consensus$-0.45

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All DFTX earnings ยท Back to DFTX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.